President Donald Trump signed an executive order Saturday that he said "directs the FDA to expedite their review of certain psychedelics already designated as breakthrough therapy drugs." "The executive order I'm signing, we're actually signing the executive order today, is really a moment," Trump said. "These treatments are currently in the advanced stages of clinical trials to ensure that they're both safe and effective for the American patients." The president said the executive order would implement "historic reforms to dramatically accelerate access to new medical research and treatments based on psychedelic drugs." "In many cases, these experimental treatments have shown...